Bliss Cunningham

I completed a PhD in 2018 from Monash University. My PhD studies focused on the development of a passive immunotherapeutic to prevent and treat Clostridium difficile infections, supported by Immuron Ltd. This work was presented at both national and international conferences, and resulted in a co-first author publication in Scientific Reports and inclusion on a patent that has been filed in Australia, Canada, Europe, USA, China and New Zealand. I’ve recently started a post-doctoral position with the McDevitt group, investigating the role of transition metal ions in pneumococcal infections.

  • Contact Details
    Department:Microbiology and Immunology
    Phone:03 9035 4473
  • Current Research Focus

    Metal ions in pneumococcal infections

    Field of ResearchDescription
    110802Medical Infection Agents (incl. Prions)
  • Key Skills
    • mouse/rat models
    • molecular biology
    • microbiology
  • Looking to collaborate?

    Microscopy, innate immunology